Abatacept - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
ORENCIA abatacept (rch) 125 mg single dose syringe subcutaneous injection ultrasafe passive needle guard and flange extender AUST R: 206764Active ingredients:
Abatacept
Dosage form:
Injection
Sponsor:
Bristol-Myers Squibb Australia Pty Ltd
Phone:
1800 067 567
|
From
08 May 2024
to
27 Aug 2024
|
Shortage status:
Resolved
Availability:
Available
Reason:
Unexpected increase in consumer demand
|
ORENCIA abatacept (rch) 125 mg single dose ClickJect prefilled autoinjector AUST R: 236039Active ingredients:
Abatacept
Dosage form:
Injection
Sponsor:
Bristol-Myers Squibb Australia Pty Ltd
Phone:
1800 067 567
|
From
08 May 2024
to
06 Aug 2024
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
Management action:
A Serious Scarcity Substitution Instrument (SSSI) has been implemented. Further information is available at: https://www.tga.gov.au/safety/shortages/medicine-shortage-alerts/substitution-approved-orencia-abatacept-shortages.
An unregistered product has been approved for supply under Section 19A. See the website: https://www.tga.gov.au/ws-sl9a-index and search for the active ingredient.
|